查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1636377

2025-2033 年胰臟癌治療和診斷市場報告（按類型（診斷、治療）、應用（醫院、診所等）和地區）

Pancreatic Cancer Therapeutics and Diagnostics Market Report by Type (Diagnostics, Treatment), Application (Hospitals, Clinics, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group，全球胰臟癌治療及診斷市場規模達45億美元。蓬勃發展的醫療保健行業、胰腺癌患病率的上升以及對殺死胰腺癌細胞的化療的需求不斷增加是推動市場發展的一些關鍵因素。

胰臟癌治療和診斷是用於診斷胰臟癌並提供治療的醫療程序。這些治療和診斷包括超音波、電腦斷層掃描 (CT) 掃描、磁振造影 (MRI) 和正子斷層掃描 (PET) 掃描。他們依靠超音波內視鏡 (EUS)，使用超音波設備從腹部內部生成胰臟影像。由於胰臟細胞生長失控，它們有助於監測腫瘤的位置。他們協助進行活組織檢查，取出一小部分組織樣本，以便在顯微鏡下檢查。它們還有助於實驗室檢查，例如全血細胞計數 (CBC)、膽道阻塞的肝臟酵素測試以及空腹血糖和糖化血紅蛋白 (HbA1C) 測試。因此，胰臟癌的治療和診斷在全球的醫院和專科中心得到了應用。

胰臟癌治療與診斷市場趨勢：

目前，由於老年人口增加和群眾過度吸菸習慣導致胰臟癌盛行率上升，是支撐市場成長的關鍵因素之一。除此之外，世界範圍內分子生物學、藥物和診斷技術的發展也在不斷發展。這與蓬勃發展的醫療保健產業目前正在推動市場的成長。此外，透過阻止胰臟癌細胞生長和分裂來殺死胰臟癌細胞的化療需求不斷增加，對市場產生了積極影響。此外，多個國家的管理機構正在大力投資胰臟癌臨床試驗和脫氧核糖核酸（DNA）修復抑制劑合併化療。他們也致力於透過批准臨床階段的藥物來促進胰腺癌治療和診斷的發展。除此之外，該行業的主要參與者正在推出一種人源化單株抗體，該抗體可促進抗腫瘤免疫反應，以治療食道癌和胃食道交界處以及胰腺癌。他們也正在開發和推出基於試劑盒的測試，透過確定 BRCA1 和 BRCA2 變異並評估基因組不穩定性來檢測胰臟癌，預計這將有助於未來幾年市場的成長。

本報告回答的關鍵問題：

  • 迄今為止，全球胰臟癌治療和診斷市場的表現如何，未來幾年將如何表現？
  • 全球胰臟癌治療和診斷市場的促進因素、限制因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的胰臟癌治療和診斷市場？
  • 依類型分類市場是怎麼樣的？
  • 胰臟癌治療和診斷市場中哪種類型最具吸引力？
  • 基於應用的市場區隔是什麼？
  • 胰臟癌治療和診斷市場中最有吸引力的應用是什麼？
  • 全球胰臟癌治療與診斷市場的競爭結構如何？
  • 誰是全球胰臟癌治療和診斷市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球胰臟癌治療與診斷市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 診斷
    • 市場趨勢
    • 關鍵環節
      • 影像學
      • 活體組織切片
      • 超音波內視鏡
      • 其他
    • 市場預測
  • 治療
    • 市場趨勢
    • 關鍵環節
      • 標靶治療
      • 化療
      • 手術
      • 其他
    • 市場預測

第 7 章：市場區隔：按應用

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AstraZeneca plc
    • F. Hoffmann-La Roche Ltd.
    • Immunovia AB
    • Novartis AG
    • Pfizer Inc.
Product Code: SR112025A7538

The global pancreatic cancer therapeutics and diagnostics market size reached USD 4.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.19% during 2025-2033. The burgeoning healthcare industry, rising prevalence of pancreatic cancer, and the escalating demand for chemotherapy to kill pancreatic cancer cells represent some of the key factors driving the market.

Pancreatic cancer therapeutics and diagnostics are medical procedures used to diagnose pancreatic cancer and provide treatment. These therapeutics and diagnostics comprise ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. They rely on an endoscopic ultrasound (EUS) that uses an ultrasound device to produce images of the pancreas from inside the abdomen. They help in monitoring the location of the tumor due to an uncontrollable growth of cells in the pancreas. They assist in performing a biopsy to remove a small sample of tissue for examination under a microscope. They also aid in laboratory investigations, such as a complete blood count (CBC), liver enzyme tests for biliary obstruction, and fasting glucose and glycated hemoglobin (HbA1C) tests. As a result, pancreatic cancer therapeutics and diagnostics find applications in hospitals and specialty centers across the globe.

Pancreatic Cancer Therapeutics and Diagnostics Market Trends:

At present, the rising prevalence of pancreatic cancer due to the increasing geriatric population and excessive smoking habits among the masses represents one of the key factors supporting the growth of the market. Besides this, there is an increase in the development of molecular biology, drugs, and diagnostic technology around the world. This, along with the thriving healthcare industry, is currently propelling the growth of the market. In addition, the escalating demand for chemotherapy to kill pancreatic cancer cells by preventing them from growing and dividing is positively influencing the market. Moreover, governing agencies of several countries are extensively investing in pancreatic cancer clinical trial testing and deoxyribonucleic acid (DNA) repair inhibitors combined with chemotherapy. They are also focusing on enhancing the growth of pancreatic cancer therapeutics and diagnostics by approving drugs in the clinical phase. Apart from this, key players operating in the industry are introducing a humanized monoclonal antibody that promotes the anti-tumor immune response for treating esophageal and gastroesophageal junction and pancreatic cancer. They are also developing and introducing kit-based testing to detect pancreatic cancer by determining BRCA1 and BRCA2 variants and assessing genomic instability, which is projected to contribute to the growth of the market in the coming years.

Key Market Segmentation:

Type Insights:

  • Diagnostics
  • Imaging
  • Biopsy
  • Endoscopic Ultrasound
  • Others
  • Treatment
  • Targeted Therapies
  • Chemotherapy
  • Surgery
  • Others

Application Insights:

  • Hospitals
  • Clinics
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for pancreatic cancer therapeutics and diagnostics. Some of the factors driving the North America pancreatic cancer therapeutics and diagnostics market included advancements in diagnostic technologies, emerging therapies and treatment options, increasing healthcare expenditure, and government initiatives and funding.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global pancreatic cancer therapeutics and diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies include AstraZeneca plc, F. Hoffmann-La Roche Ltd., Immunovia AB, Novartis AG, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global pancreatic cancer therapeutics and diagnostics market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global pancreatic cancer therapeutics and diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive pancreatic cancer therapeutics and diagnostics markets?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the pancreatic cancer therapeutics and diagnostics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the pancreatic cancer therapeutics and diagnostics market?
  • What is the competitive structure of the global pancreatic cancer therapeutics and diagnostics market?
  • Who are the key players/companies in the global pancreatic cancer therapeutics and diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pancreatic Cancer Therapeutics and Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Imaging
      • 6.1.2.2 Biopsy
      • 6.1.2.3 Endoscopic Ultrasound
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Treatment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Targeted Therapies
      • 6.2.2.2 Chemotherapy
      • 6.2.2.3 Surgery
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AstraZeneca plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 F. Hoffmann-La Roche Ltd.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Immunovia AB
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Novartis AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Pfizer Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: North America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: North America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: United States: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: United States: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: China: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: China: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: India: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: India: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: France: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: France: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 65: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 67: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Value Chain Analysis
  • Figure 68: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Competitive Structure
  • Table 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Players